TipRanks
Merck & Company (CH:6MK)
:6MK
Switzerland Market
6MK
Merck & Company
RESEARCH TOOLSreports

Merck & Company (6MK) Stock News & Sentiment

0 Followers
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
Premium
Market News
Warner Bros. Is Set to Leave Nasdaq 100 and S&P 500 Indexes after $81 Billion Paramount Buyout
3d ago
ICE
MRK
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
Premium
Market News
3 ETFs to Buy with At Least 13% Upside Potential, According to the AI Analyst
3d ago
MRK
VUG
Merck: Emerging Immunology Strength and HS Execution Support Unchanged $160 Price Target and Buy Rating
Premium
Ratings
Merck: Emerging Immunology Strength and HS Execution Support Unchanged $160 Price Target and Buy Rating
3d ago
MRK
Merck Buy Rating Reiterated as Compelling Tulisokibart Data and Diversified Pipeline Support Outlook; $170 Price Target Maintained
Premium
Ratings
Merck Buy Rating Reiterated as Compelling Tulisokibart Data and Diversified Pipeline Support Outlook; $170 Price Target Maintained
4d ago
MRK
3 ETF Bets with 11%+ Upside, According to AI Analyst
Premium
Market News
3 ETF Bets with 11%+ Upside, According to AI Analyst
5d ago
PH
CRM
3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst
Premium
Market News
3 ETFs That Could Deliver 11%+ Returns, According to the AI Analyst
11d ago
VZ
COP
Merck: Catalyst-Rich Oncology and Immunology Pipeline Supports Buy Rating; $166 Price Target Reaffirmed
Premium
Ratings
Merck: Catalyst-Rich Oncology and Immunology Pipeline Supports Buy Rating; $166 Price Target Reaffirmed
12d ago
MRK
More CH:6MK News >

6MK News on the Web

Merck & Co. (MRK) -- Healthcare Innovation and Dividend Growth | Thornburg Investment ...
GuruFocus News
Bullish
Merck (MRK) Reports Positive Phase 2b Trial Results for Tulisokibart in Hidradenitis Suppurativa
GuruFocus News
Bullish
JPMorgan U.S. Momentum Factor ETF (JMOM) Buys $27.6 Million More Merck on Sept. 28
GuruFocus News
Neutral
Moderna has been on a tear since mid-August. Citi now sees it plunging 60%
CNBC
Neutral
3 ETF Bets with 11%+ Upside, According to AI Analyst
TipRanks News
Bullish
Merck Stock Slips 1.5% as $400 Million Buys KRAS Rights
GuruFocus News
Bearish
Citi Remains a Hold on Merck & Company (MRK)
TipRanks News
Neutral
Bank of America has strong message for Merck stock investors
TheStreet.com
Bullish

News Score - Last 7 Days

Very Positive
CH:6MK
Sector Average
Media Buzz
This Week40 articles
Weekly Average27.5 articles
News Sentiment
This Week94%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:6MK’s Media Buzz Sentiment?
40 articles about CH:6MK were published this week. In an average week, 27.5 articles are published.
    What is CH:6MK’s weekly average amount of articles?
    In an average week, 27.5 articles about CH:6MK are published.
      What is CH:6MK’s News Sentiment?
      94% of articles about CH:6MK were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        ABTAbbott Laboratories
        INCYIncyte
        SMMTSummit Therapeutics
        CRVOCervoMed
        Showing the stocks with the most bullish news sentiment over the past week